Intelligence · Clinical pipeline
Neurology & CNS · Phase III
Neurology & CNS programs at Phase III — ClinicalTrials.gov pipeline intelligence.
Quick answer
Neurology & CNS Phase III programs: NovaPharmaNews indexes 213 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- HOFFMANN-LA ROCHE 21 programs
- Teva Pharma 12 programs
- Novartis India 10 programs
- Takeda 10 programs
- Bristol-Myers Squibb Australia 9 programs
- Jazz Pharmaceuticals Ireland 7 programs
- Biogen 6 programs
- TG THERAPEUTICS 6 programs
- Acadia Pharmaceuticals 5 programs
- Anaxis Pharma 5 programs
- NEUROCRINE BIOSCIENCES 5 programs
- SUPERNUS PHARMACEUTICALS 5 programs
Pipeline programs
-
WO46069
Hoffmann-La Roche
Pretreated Unresectable Locally Advanced or Metastatic human epidermal growth factor receptor 2 (HER2)-Positive Breast Cancer, with or without Central Nervous System (CNS) Metastases
1 trial -
XEN1101
Xenon Pharmaceuticals
Focal Epilepsy
2 trials -
XEN496
Xenon Pharmaceuticals
Epilepsy
2 trials -
XPF-010
Xenon Pharmaceuticals
Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)
1 trial -
Xanomeline and Trospium Chloride Capsules
Bristol-Myers Squibb Australia Pty Ltd
Schizophrenia
1 trial -
ZB020-03-001
Zenas BioPharma
Primary Progressive Multiple Sclerosis (PPMS)
1 trial -
ZB203L01
Zambon SpA
Motor fluctuations in advanced Parkinson’s disease
1 trial -
Zonisamide
Eisai Co.,
Epilepsy
1 trial -
apomorphine infusion
SUPERNUS PHARMACEUTICALS, INC.
Idiopathic Parkinson's Disease
1 trial -
bapineuzumab
Pfizer
Alzheimer Disease
1 trial -
copolymer 1
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
dimethyl fumarate
Biogen
Relapsing-Remitting Multiple Sclerosis
1 trial -
gabapentin
Pfizer
Epilepsies, Partial
1 trial -
immune globulin
Ultragenyx UK Limited
Multiple Sclerosis
1 trial -
lamotrigine, 300 mg/day
GlaxoSmithKline
Epilepsy, Partial
1 trial -
mifepristone
CORCEPT THERAPEUTICS INC
Psychotic Depression
1 trial -
perampanel
Eisai Co.,
Epilepsy
2 trials -
pimavanserin tartrate
Acadia Pharmaceuticals B.V.
Parkinson's Disease Psychosis
1 trial -
placebo
Pfizer
Schizophrenia
1 trial -
ublituximab
TG THERAPEUTICS, INC.
relapsing multiple sclerosis
1 trial -
vormatrogine
Chongqing Precision Biotech Co., Ltd
Epilepsy, Tonic-Clonic
1 trial
Frequently asked questions
How many neurology & cns Phase III programs exist?
213 programs match both the therapeutic area and stage filters in our published index.